EECP In Patients With Ischemic Heart Failure

EECP In Patients With Ischemic Heart Failure
Written by: Flow Therapy

This post is an excerpt from an article originally published in 2012 by the National Library of Medicine. Click the link at the bottom to read the full article.

Clinical effects of enhanced external counterpulsation treatment in patients with ischemic heart failure

Objective: Enhanced external counterpulsation (EECP) is a noninvasive treatment that is proven safe and effective in patients with coronary artery disease (CAD) and heart failure (HF). The aims of this study are to investigate the clinical effects of EECP therapy in patients with symptomatic CAD and chronic HF, and to find out an answer to the question: Does EECP therapy have any effect on the prognostic markers of HF?

Methods: This study was designed as a prospective cohort study. A total of 68 consecutive patients with symptomatic CAD and chronic HF referred to EECP therapy were enrolled in this study between November 2007 and December 2010; 47 patients (39 males and 8 females, 65 ± 7, years), have undergone EECP treatment, and 21 patients (20 males and 1 female, 62 ± 10 years), who did not want to participate in the EECP program comprised the control group. Statistical analysis was performed using t tests for dependent and independent samples, Mann-Whitney U test, Chi-square and Fischer exact tests.


More EECP Resources

Non-Invasive EECP Therapy for Angina & Heart Failure

The future of EECP stretches beyond medical management.

Read More

Evidence for EECP Therapy as Heart Failure Management Tool

Learn about balloon counterpulsation as a therapy for cardiogenic shock.

Read More

How EECP Improves Exercise Tolerance in Patients with Chronic Heart Failure

Exercise tolerance, quality of life, and NYHA functional classification.

Read More